| scholarly article | Q13442814 |
| P2093 | author name string | Sheetij Dutta | |
| Robert A Gasser | |||
| J David Haynes | |||
| Adrian H Batchelor | |||
| Christopher D Pool | |||
| Lisa S Dlugosz | |||
| Joshua W Clayton | |||
| P2860 | cites work | Reduction of the inhibitory antibody response to human factor VIII in hemophilia A mice by mutagenesis of the A2 domain B-cell epitope | Q45874416 |
| Allelic polymorphisms in apical membrane antigen-1 are responsible for evasion of antibody-mediated inhibition in Plasmodium falciparum | Q47864459 | ||
| Apical membrane antigen 1 plays a central role in erythrocyte invasion by Plasmodium species | Q47874885 | ||
| Crystal structure of the malaria vaccine candidate apical membrane antigen 1. | Q48004368 | ||
| The disulfide bond structure of Plasmodium apical membrane antigen-1. | Q48033627 | ||
| Fine mapping of an epitope recognized by an invasion-inhibitory monoclonal antibody on the malaria vaccine candidate apical membrane antigen 1. | Q48037113 | ||
| Quality and quantity of the humoral immune response in healthy elderly and young subjects after annually repeated influenza vaccination. | Q50636460 | ||
| Structural comparison of apical membrane antigen 1 orthologues and paralogues in apicomplexan parasites | Q56441125 | ||
| A new method for determination of varicella-zoster virus immunoglobulin G avidity in serum and cerebrospinal fluid | Q24799955 | ||
| Structure of the Malaria Antigen AMA1 in Complex with a Growth-Inhibitory Antibody | Q27648686 | ||
| High antibody titer against apical membrane antigen-1 is required to protect against malaria in the Aotus model | Q28749979 | ||
| Erythrocytic malaria growth or invasion inhibition assays with emphasis on suspension culture GIA. | Q33183956 | ||
| Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: results of a phase 1 randomized controlled trial | Q33316023 | ||
| Plasmodium falciparum: development and validation of a measure of intraerythrocytic growth using SYBR Green I in a flow cytometer | Q33385396 | ||
| An inhibitory antibody blocks interactions between components of the malarial invasion machinery | Q33402457 | ||
| Phase 1/2a study of the malaria vaccine candidate apical membrane antigen-1 (AMA-1) administered in adjuvant system AS01B or AS02A. | Q33434412 | ||
| Extreme polymorphism in a vaccine antigen and risk of clinical malaria: implications for vaccine development | Q33654911 | ||
| Structure of AMA1 from Plasmodium falciparum reveals a clustering of polymorphisms that surround a conserved hydrophobic pocket | Q33943794 | ||
| Comparing antigenicity and immunogenicity of engineered gp120. | Q33984309 | ||
| Specificity of the protective antibody response to apical membrane antigen 1 | Q34007362 | ||
| Purification, characterization, and immunogenicity of the refolded ectodomain of the Plasmodium falciparum apical membrane antigen 1 expressed in Escherichia coli | Q34122492 | ||
| In vitro studies with recombinant Plasmodium falciparum apical membrane antigen 1 (AMA1): production and activity of an AMA1 vaccine and generation of a multiallelic response | Q34260615 | ||
| Vaccination of monkeys with recombinant Plasmodium falciparum apical membrane antigen 1 confers protection against blood-stage malaria | Q34260722 | ||
| Identification of T-cell determinants in natural immune responses to the Plasmodium falciparum apical membrane antigen (AMA-1) in an adult population exposed to malaria | Q35477854 | ||
| Structural basis of antigenic escape of a malaria vaccine candidate | Q35927982 | ||
| Population structure of the genes encoding the polymorphic Plasmodium falciparum apical membrane antigen 1: implications for vaccine design | Q36693957 | ||
| Selective modification of variable loops alters tropism and enhances immunogenicity of human immunodeficiency virus type 1 envelope | Q37092741 | ||
| A randomized controlled phase 2 trial of the blood stage AMA1-C1/Alhydrogel malaria vaccine in children in Mali | Q37267850 | ||
| Allele Frequency-Based Analyses Robustly Map Sequence Sites Under Balancing Selection in a Malaria Vaccine Candidate Antigen | Q39362577 | ||
| Phase I dose escalation safety and immunogenicity trial of Plasmodium falciparum apical membrane protein (AMA-1) FMP2.1, adjuvanted with AS02A, in malaria-naïve adults at the Walter Reed Army Institute of Research. | Q40144102 | ||
| Refocusing neutralizing antibody response by targeted dampening of an immunodominant epitope. | Q41103077 | ||
| Prediction of residues in discontinuous B-cell epitopes using protein 3D structures | Q41926924 | ||
| Mode of action of invasion-inhibitory antibodies directed against apical membrane antigen 1 of Plasmodium falciparum | Q42727356 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | L-alanine | Q218642 |
| P304 | page(s) | 661-671 | |
| P577 | publication date | 2009-11-30 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Alanine mutagenesis of the primary antigenic escape residue cluster, c1, of apical membrane antigen 1. | |
| P478 | volume | 78 |
| Q33545251 | 3D analysis of the TCR/pMHCII complex formation in monkeys vaccinated with the first peptide inducing sterilizing immunity against human malaria |
| Q36511421 | A full-length recombinant Plasmodium falciparum PfRH5 protein induces inhibitory antibodies that are effective across common PfRH5 genetic variants |
| Q34663978 | Blood stage vaccines for Plasmodium falciparum: current status and the way forward |
| Q34507190 | Defining the antigenic diversity of Plasmodium falciparum apical membrane antigen 1 and the requirements for a multi-allele vaccine against malaria |
| Q36514853 | Designing malaria vaccines to circumvent antigen variability |
| Q64110597 | Effect of low complexity regions within the PvMSP3α block II on the tertiary structure of the protein and implications to immune escape mechanisms |
| Q33828593 | Genetic mapping identifies novel highly protective antigens for an apicomplexan parasite |
| Q35037036 | Global Population Structure of the Genes Encoding the Malaria Vaccine Candidate, Plasmodium vivax Apical Membrane Antigen 1 (PvAMA1). |
| Q35683634 | Identification of an Immunogenic Mimic of a Conserved Epitope on the Plasmodium falciparum Blood Stage Antigen AMA1 Using Virus-Like Particle (VLP) Peptide Display |
| Q90009659 | Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination |
| Q36509831 | Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications |
| Q35079832 | Overcoming antigenic diversity by enhancing the immunogenicity of conserved epitopes on the malaria vaccine candidate apical membrane antigen-1. |
| Q36394182 | Recent advances in recombinant protein-based malaria vaccines |
| Q55429433 | Structural patterns of selection and diversity for Plasmodium vivax antigens DBP and AMA1. |
| Q34596157 | Use of immunodampening to overcome diversity in the malarial vaccine candidate apical membrane antigen 1. |
| Q27024344 | Vaccines for malaria: how close are we? |
Search more.